B
BioLife Solutions, Inc.
BLFS · NASDAQ · Healthcare · 1.7B
Price · close
$37.10
+0.35% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.8×
Enterprise value / EBITDAEV/EBITDA
487.1×
Free cash flow yieldFCF yield
0.0%
Return on equityROE
-3.3%
Operating margin
-1.1%
Net debt / EBITDAbalance-sheet strength
-4.2×
Interest coverage
-0.4×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.